Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, More
Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near all-time highs.
Some return buyers were among the insiders acquiring shares this last week.
A beauty products company and an online dating outfit were among the firms that saw notable insider buying.
Selecta Biosciences Files For U.S. Patent Application Titled ‘METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASES AND DISORDERS’
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=370&f=G&l=50&d=PG01&s1=%22*%22&p=8&OS=
60 Biggest Movers From Yesterday
Gainers
Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday.
ROCE Insights For Selecta Biosciences
Selecta Biosciences (NASDAQ:SELB) reported Q1 sales of $11.05 million. Earnings fell to a loss of $7.16 million, resulting in a 9.37% decrease from last quarter. Selecta Biosciences collected $11.95 million in revenue during Q4, but reported earnings showed a $7.90 million loss.
Recap: Selecta Biosciences Q1 Earnings
Shares of Selecta Biosciences (NASDAQ:SELB) remained unaffected after the company reported Q1 results.
Quarterly Results
Earnings per share were down 4.76% year over year to ($0.22), which missed the estimate of ($0.12).
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.
65 Biggest Movers From Yesterday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.